Source link : https://newshealth.biz/health-news/key-her2-positive-breast-cancer-therapy-gets-its-first-biosimilar/
(MedPage Today) — The FDA approved pertuzumab-dpzb (Poherdy) as the first biosimilar for its reference product Perjeta, a monoclonal antibody commonly used in standard regimens for HER2-positive breast cancer. FDA granted the targeted agent an… Source link : https://www.medpagetoday.com/hematologyoncology/breastcancer/118513 Author : Publish date : 2025-11-13 21:29:00 Copyright for syndicated content belongs to the linked Source.
The post Key HER2-Positive Breast Cancer Therapy Gets Its First Biosimilar first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-13 21:29:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8